GORLIN STEVE

Average Profitability
55.41%
Insider Buys Quantity
38
Insider Buys Sum
$1.13M
Insider Sells Quantity
41
Insider Sells Sum
$18.77M

Insider Activity of GORLIN STEVE

The largest purchase of all time was on 2014-12-22 and amounted to 150000 shares of Ontrak, Inc. for $300,000.

The largest sale of all time was on 2015-08-21 and amounted to 450000 shares of ImmunityBio, Inc. for $10.35M.

Biography of GORLIN STEVE

No biography is available at this moment.

2023-12-01SaleBioVie Inc.
BIVI
director
75,680
0.2029%
$1.69$127,899-71.43%
2023-09-05SaleBioVie Inc.
BIVI
director
8,560
0.023%
$3.05$26,108-70.38%
2020-11-03PurchaseBioVie Inc.
BIVI
director
2,430
0.0171%
$7.95$19,319+78.22%
2020-10-30PurchaseBioVie Inc.
BIVI
director
2,570
0.0185%
$7.97$20,483+81.68%
2020-10-21PurchaseBioVie Inc.
BIVI
director
5,000
0.0362%
$9.19$45,950+58.95%
2020-10-15PurchaseBioVie Inc.
BIVI
director
15,100
0.1065%
$10.10$152,517+40.72%
2020-10-09PurchaseBioVie Inc.
BIVI
director
282
0.002%
$9.61$2,710+50.83%
2020-10-07PurchaseBioVie Inc.
BIVI
director
4,718
0.0343%
$9.42$44,444+55.36%
2020-09-22PurchaseBioVie Inc.
BIVI
director
15,000
0.263%
$10.00$150,000+51.62%
2018-11-29SaleImmunityBio, Inc.
IBRX
director
172,368
0.2108%
$1.66$286,061-28.74%
2018-11-28SaleImmunityBio, Inc.
IBRX
director
17,140
0.0213%
$1.76$30,125-31.61%
2018-11-27SaleImmunityBio, Inc.
IBRX
director
100,000
0.1225%
$1.75$175,200-32.39%
2018-11-23SaleImmunityBio, Inc.
IBRX
director
9,312
0.0118%
$2.01$18,717-38.97%
2018-11-21SaleImmunityBio, Inc.
IBRX
director
22,900
0.0284%
$2.02$46,217-40.5%
2018-11-14SaleImmunityBio, Inc.
IBRX
director
115,930
0.143%
$2.21$255,718-45.45%
2018-11-13SaleImmunityBio, Inc.
IBRX
director
33,300
0.0415%
$2.40$79,887-49.37%
2018-11-12SaleImmunityBio, Inc.
IBRX
director
47,050
0.0597%
$2.43$114,463-49.15%
2018-08-27SaleImmunityBio, Inc.
IBRX
director
18,300
0.0232%
$3.09$56,463-58.63%
2018-08-24SaleImmunityBio, Inc.
IBRX
director
10,225
0.013%
$3.07$31,341-58.22%
2018-08-23SaleImmunityBio, Inc.
IBRX
director
21,475
0.0274%
$3.06$65,709-58.09%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.